A previous study that detected salivary cytokines in patients with head and neck cancer with concurrent CTx and RT reported a significant increase in the salivary levels of IL-1β, IL-6, and TNF, that were all positively associated with the mucosal toxicity severity [10]. This evidence concerns the gene IL1B and head and neck cancer.